MA22806A1 - Procede de preparation d'arylcarbonyl laminoalkyl-dihydro-oxopyridines et leur utilisation. - Google Patents

Procede de preparation d'arylcarbonyl laminoalkyl-dihydro-oxopyridines et leur utilisation.

Info

Publication number
MA22806A1
MA22806A1 MA23099A MA23099A MA22806A1 MA 22806 A1 MA22806 A1 MA 22806A1 MA 23099 A MA23099 A MA 23099A MA 23099 A MA23099 A MA 23099A MA 22806 A1 MA22806 A1 MA 22806A1
Authority
MA
Morocco
Prior art keywords
treatment
disturbances
hydrogen
compounds
loweralkyl
Prior art date
Application number
MA23099A
Other languages
English (en)
Inventor
Manta Dieter
Klaus Erik
Englert Heinreich
Wettlanfer David
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of MA22806A1 publication Critical patent/MA22806A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
MA23099A 1992-02-20 1993-02-19 Procede de preparation d'arylcarbonyl laminoalkyl-dihydro-oxopyridines et leur utilisation. MA22806A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92102828 1992-02-20

Publications (1)

Publication Number Publication Date
MA22806A1 true MA22806A1 (fr) 1993-10-01

Family

ID=8209352

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23099A MA22806A1 (fr) 1992-02-20 1993-02-19 Procede de preparation d'arylcarbonyl laminoalkyl-dihydro-oxopyridines et leur utilisation.

Country Status (17)

Country Link
US (1) US5360808A (fr)
EP (1) EP0556738B1 (fr)
JP (1) JPH069560A (fr)
KR (1) KR930017895A (fr)
CN (1) CN1075480A (fr)
AT (1) ATE122659T1 (fr)
AU (1) AU3375993A (fr)
CA (1) CA2089955A1 (fr)
CZ (1) CZ403592A3 (fr)
DE (1) DE69300152D1 (fr)
FI (1) FI930716A (fr)
HU (1) HU9300463D0 (fr)
IL (1) IL104781A0 (fr)
MA (1) MA22806A1 (fr)
MX (1) MX9300915A (fr)
NO (1) NO930594L (fr)
ZA (1) ZA931185B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020052295A1 (en) * 1999-12-21 2002-05-02 Hegde Shridhar G. Diacyl derivatives of propylene diamine having herbicidal activity
DE10205219A1 (de) * 2002-02-08 2003-08-21 Bayer Ag Chinoxalinone und ihre Verwendung
US6869966B2 (en) * 2002-09-30 2005-03-22 Banyu Pharmaceutical Co., Ltd. N-substituted-2-oxodihydropyridine derivatives
US20040127129A1 (en) * 2002-12-31 2004-07-01 Shuiyuan Luo Grooved-shape monofilaments and the fabrics made thereof
WO2007008963A1 (fr) * 2005-07-13 2007-01-18 Jenrin Discovery Inhibiteurs de la mao-b utiles pour traiter l'obésité
EP2114898A2 (fr) * 2007-02-16 2009-11-11 Amgen Inc. Cétones d'hétérocyclyle contenant de l'azote et procédés d'utilisation
US8153808B2 (en) 2008-12-23 2012-04-10 Roche Palo Alto Llc Dihydropyridone amides as P2X7 modulators
WO2010072599A1 (fr) 2008-12-23 2010-07-01 F. Hoffmann-La Roche Ag Dihydropyridone urées en tant que modulateurs de p2x7
CA2745952A1 (fr) 2008-12-23 2010-07-01 F.Hoffmann-La Roche Ag Amides de dihydropyridone utiles comme modulateurs de p2x7
KR101381074B1 (ko) 2008-12-23 2014-04-11 에프. 호프만-라 로슈 아게 Ｐ2ｘ7 조절제로서의 디히드로피리돈 아미드
SG172785A1 (en) 2008-12-23 2011-08-29 Hoffmann La Roche Dihydropyridone amides as p2x7 modulators
WO2011023696A1 (fr) 2009-08-26 2011-03-03 Nycomed Gmbh Méthylpyrrolopyrimidine-carboxamides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2637477A1 (de) * 1976-08-20 1978-02-23 Hoechst Ag Dihydro-oxo-nicotinsaeuren und verfahren zu ihrer herstellung
US4297360A (en) * 1980-03-28 1981-10-27 Sterling Drug Inc. 5-(Pyridinyl)pyridine-2,3-diamines, preparation thereof and their cardiotonic use
NZ195564A (en) * 1979-11-26 1983-09-30 Sterling Drug Inc 5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds
IT8367883A0 (it) * 1982-08-23 1983-08-22 Rorer Int Overseas Composti cardiotonici del 2 piridone 5 biciclico eteroaril sostituito e relative composizioni farmaceutiche
GB8809481D0 (en) * 1988-04-21 1988-05-25 Smith Kline French Lab Chemical compounds

Also Published As

Publication number Publication date
DE69300152D1 (de) 1995-06-22
EP0556738B1 (fr) 1995-05-17
EP0556738A1 (fr) 1993-08-25
MX9300915A (es) 1993-09-01
ZA931185B (en) 1993-09-16
CA2089955A1 (fr) 1993-08-21
NO930594D0 (no) 1993-02-19
CZ403592A3 (en) 1993-12-15
AU3375993A (en) 1993-08-26
US5360808A (en) 1994-11-01
IL104781A0 (en) 1993-06-10
KR930017895A (ko) 1993-09-20
FI930716A (fi) 1993-08-21
NO930594L (no) 1993-08-23
JPH069560A (ja) 1994-01-18
ATE122659T1 (de) 1995-06-15
FI930716A0 (fi) 1993-02-18
HU9300463D0 (en) 1993-05-28
CN1075480A (zh) 1993-08-25

Similar Documents

Publication Publication Date Title
MA22806A1 (fr) Procede de preparation d'arylcarbonyl laminoalkyl-dihydro-oxopyridines et leur utilisation.
PH31123A (en) Benzimidazole compounds.
TNSN94106A1 (fr) Amide tricyclique et composes d'uree utiles pour l'inhibition de la fonction proteine g et pour le traitement des maladies proliferatives
AU610739B2 (en) Thiazolo (5,4-b)azepine compounds
ATE140920T1 (de) Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung
DE69330282T2 (de) Chinolon und acridinon derivate zur behandlung der harninkontinenz
DE3776632D1 (de) 5-pentylamino-5 oxo-pentansaeure und 4-pentylamino-4-oxobuttersaeure derivate mit cholecytokinin-antagonistischer aktivitaet und verfahren zu ihrer herstellung.
US4455307A (en) Antihypertensive use of triazolobenzodiazepines
PH27409A (en) Benzocycloalkylaminopyrimidines and related compounds as topical antiinflammatory agents for the treatment of skin disorders
Monge et al. 3‐Amino‐2‐quinoxalinecarbonitrile. New fused quinoxalines with potential cytotoxic activity
AU621388B2 (en) The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
DE59611123D1 (de) Aromatische carbonsäureester, ihre herstellung und verwendung als heilmittel
HRP920948A2 (en) Nitratoalkanecarbone acid derivatives, process for the preparation thereof, the use of the same and drugs containing them
ATE146176T1 (de) Benzo(b)thiophen-3-yl-piperazine, verfahren zur deren herstellung und ihre verwendung als arzneimittel
RU93004478A (ru) Новые арилкарбониламиноалкил-дигидро-оксо-пиридины, их получение и их применение
DE68906647D1 (de) Hydroxy-1,2,3,4-tetrahydroaminoacridine, verfahren fuer ihre herstellung und ihre verwendung als arzneimittel.
DE3850215T2 (de) 1-Acyl-2,3-dihydro-4(1H)-chinolon-4-oxim-Derivate, Verfahren zu ihrer Herstellung und Verwendung davon.
JPS61268651A (ja) フエニル酢酸誘導体およびその製造法
RO88666A (fr) Procede d'obtention des derive de 6 alpha-methylprednisolon
US5364878A (en) Use of substituted 3,4-dihydro-2H-benzopyrans as remedies for obstructive functional disorders of the lungs
Shutalev et al. Synthesis and steric structure of 4-arylaminohexahydropyrimidine-2-thiones
JPS61143337A (ja) 安息香酸誘導体およびその製造法